Due to the involvement of mGluR5 in AD pathology and its therapeutic potential, investigating the correlations among various biomarkers in the complex pathogenesis of AD is highly intriguing to elucidate the development and progression of the disease. This evidence concerns the gene GRM5 and Alzheimer disease.